NEW YORK (Reuters Health) - The immune-modulating drug leflunomide is effective as co-therapy with drugs that block the inflammation-producing protein TNF in people with rheumatoid arthritis, according to a report published this month.
NEW YORK (Reuters Health) - The immune-modulating drug leflunomide is effective as co-therapy with drugs that block the inflammation-producing protein TNF in people with rheumatoid arthritis, according to a report published this month.
